» Articles » PMID: 35393945

Gene Therapy of Csf2ra Deficiency in Mouse Fetal Monocyte Precursors Restores Alveolar Macrophage Development and Function

Overview
Journal JCI Insight
Date 2022 Apr 8
PMID 35393945
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-resident macrophage-based immune therapies have been proposed for various diseases. However, generation of sufficient numbers that possess tissue-specific functions remains a major handicap. Here, we showed that fetal liver monocytes cultured with GM-CSF (CSF2-cFLiMo) rapidly differentiated into a long-lived, homogeneous alveolar macrophage-like population in vitro. CSF2-cFLiMo retained the capacity to develop into bona fide alveolar macrophages upon transfer into Csf2ra-/- neonates and prevented development of alveolar proteinosis and accumulation of apoptotic cells for at least 1 year in vivo. CSF2-cFLiMo more efficiently engrafted empty alveolar macrophage niches in the lung and protected mice from severe pathology induced by respiratory viral infection compared with transplantation of macrophages derived from BM cells cultured with M-CSF (CSF1-cBMM) in the presence or absence of GM-CSF. Harnessing the potential of this approach for gene therapy, we restored a disrupted Csf2ra gene in fetal liver monocytes and demonstrated their capacity to develop into alveolar macrophages in vivo. Altogether, we provide a platform for generation of immature alveolar macrophage-like precursors amenable for genetic manipulation, which will be useful to dissect alveolar macrophage development and function and for pulmonary transplantation therapy.

Citing Articles

The role of alveolar macrophages in viral respiratory infections and their therapeutic implications.

Javaherdehi A, Ghanbari S, Mahdavi P, Zafarani A, Razizadeh M Biochem Biophys Rep. 2024; 40:101826.

PMID: 39324036 PMC: 11422589. DOI: 10.1016/j.bbrep.2024.101826.


Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression.

Tzetzo S, Kramer E, Mohammadpour H, Kim M, Rosario S, Yu H iScience. 2024; 27(3):109187.

PMID: 38420590 PMC: 10901102. DOI: 10.1016/j.isci.2024.109187.


Macrophage-Derived Exosomes as Advanced Therapeutics for Inflammation: Current Progress and Future Perspectives.

Song Y, Hu J, Ma C, Liu H, Li Z, Yang Y Int J Nanomedicine. 2024; 19:1597-1627.

PMID: 38406601 PMC: 10888065. DOI: 10.2147/IJN.S449388.


Adaptation of Human iPSC-Derived Macrophages Toward an Alveolar Macrophage-Like Phenotype Post-Intra-Pulmonary Transfer into Murine Models.

Hetzel M, Gensch I, Ackermann M, Lachmann N Methods Mol Biol. 2023; 2713:463-479.

PMID: 37639142 DOI: 10.1007/978-1-0716-3437-0_31.


Shaping of the alveolar landscape by respiratory infections and long-term consequences for lung immunity.

Rodriguez-Rodriguez L, Gillet L, Machiels B Front Immunol. 2023; 14:1149015.

PMID: 37081878 PMC: 10112541. DOI: 10.3389/fimmu.2023.1149015.


References
1.
Duan Z, Luo Y . Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther. 2021; 6(1):127. PMC: 7994399. DOI: 10.1038/s41392-021-00506-6. View

2.
Suzuki T, Sakagami T, Rubin B, Nogee L, Wood R, Zimmerman S . Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008; 205(12):2703-10. PMC: 2585845. DOI: 10.1084/jem.20080990. View

3.
Iscove N, Nawa K . Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion. Curr Biol. 1997; 7(10):805-8. DOI: 10.1016/s0960-9822(06)00341-1. View

4.
Robb L, Drinkwater C, Metcalf D, Li R, Kontgen F, Nicola N . Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A. 1995; 92(21):9565-9. PMC: 40842. DOI: 10.1073/pnas.92.21.9565. View

5.
Hussell T, Bell T . Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014; 14(2):81-93. DOI: 10.1038/nri3600. View